In this article, we summarize the progress of interplay between the PTH1R and CaSR signaling in a vicious cycle of BrCa bone metastases, and interference of these interactions could offer new treatment options of BrCa bone metastases and their complications. Here, PTH1R is linked to invasive breast carcinoma.